Vir Biotechnology Receives FDA IND Clearance and Fast Track Designation for Tobevibart and Elebsiran for the Treatment of Chronic Hepatitis Delta Infection

View Full Size 

Download

• Full Size JPEG, 1053x512, 71.4 KB
• Small JPEG, 480x233, 38.4 KB
• Preview JPEG, 144x70, 10.9 KB
• Thumbnail JPEG, 120x58, 8.6 KB